Singapore, Brazil lead country ETF gains as South Korea's AI rally unwinds
Genomics gained 21.1% during the month, followed by biotech at 16.2%, cybersecurity at 13.7% and insurance at 10.7%, as investors shifted away from crowded AI-linked trades.
Genomics gained 21.1% during the month, followed by biotech at 16.2%, cybersecurity at 13.7% and insurance at 10.7%, as investors shifted away from crowded AI-linked trades.
What's Your Reaction?
